Andrew Callos 10b5-1 sales reported for CYTK (NASDAQ: CYTK)
Rhea-AI Filing Summary
Andrew Callos reported multiple planned sales of Common Stock under a Rule 10b5-1 plan. The filing lists individual dispositions dated between
Positive
- None.
Negative
- None.
Insights
Insider executed scheduled 10b5-1 sales across multiple dates; pattern consistent with pre-arranged liquidity.
Andrew Callos reports a sequence of dispositions labeled as 10b5-1 Sales, with multiple entries of
These entries reflect pre-arranged trading activity; cash‑flow treatment to the selling holder is clear from the schedule, and timing follows the plan dates shown in the excerpt.
FAQ
What did the Form 144 for CYTK disclose about insider sales?
How many shares did Andrew Callos sell on key dates in the filing?
Were the sales described as part of a trading plan in the Form 144?
What proceeds are listed for the reported transactions in the filing?